Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel.
about
A novel and selective poly (ADP-ribose) polymerase inhibitor ameliorates chemotherapy-induced painful neuropathyMethylglyoxal evokes pain by stimulating TRPA1Mitotoxicity in distal symmetrical sensory peripheral neuropathiesInhibition of Mitochondrial p53 Accumulation by PFT-μ Prevents Cisplatin-Induced Peripheral Neuropathy.Mangafodipir a Selective Cytoprotectant - with Special Reference to Oxaliplatin and Its Association to Chemotherapy-Induced Peripheral Neuropathy (CIPN)The development and maintenance of paclitaxel-induced neuropathic pain require activation of the sphingosine 1-phosphate receptor subtype 1.Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons.Spinal neuroimmune activation is independent of T-cell infiltration and attenuated by A3 adenosine receptor agonists in a model of oxaliplatin-induced peripheral neuropathy.Antinociceptive activity of transient receptor potential channel TRPV1, TRPA1, and TRPM8 antagonists in neurogenic and neuropathic pain models in mice.Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy.Aqueous extract of Lithospermi radix attenuates oxaliplatin-induced neurotoxicity in both in vitro and in vivo modelsCharacterisation of Immune and Neuroinflammatory Changes Associated with Chemotherapy-Induced Peripheral Neuropathy.Chemotherapy-induced peripheral neuropathy: Current status and progress.Pharmacological comparison of a nonhuman primate and a rat model of oxaliplatin-induced neuropathic cold hypersensitivity.NON-INVASIVE EVALUATION OF NERVE CONDUCTION IN SMALL DIAMETER FIBERS IN THE RAT.Bioenergetic deficits in peripheral nerve sensory axons during chemotherapy-induced neuropathic pain resulting from peroxynitrite-mediated post-translational nitration of mitochondrial superoxide dismutase.Aromatase inhibitors augment nociceptive behaviors in rats and enhance the excitability of sensory neurons.Sustained Accumulation of Microtubule-Binding Chemotherapy Drugs in the Peripheral Nervous System: Correlations with Time Course and Neurotoxic Severity.Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapyPrevention of chemotherapy-induced peripheral neuropathy by the small-molecule inhibitor pifithrin-μ.An animal model of oxaliplatin-induced cold allodynia reveals a crucial role for Nav1.6 in peripheral pain pathwaysChemotherapy-induced painful neuropathy: pain-like behaviours in rodent models and their response to commonly used analgesics"Bedside-to-Bench" Behavioral Outcomes in Animal Models of Pain: Beyond the Evaluation of Reflexes.Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN).Genetic inactivation and pharmacological blockade of sigma-1 receptors prevent paclitaxel-induced sensory-nerve mitochondrial abnormalities and neuropathic pain in mice.Monocytes expressing CX3CR1 orchestrate the development of vincristine-induced pain.Understanding the role of mitochondria in the pathogenesis of chronic pain.Mechanisms of distal axonal degeneration in peripheral neuropathies.Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives.Translesion Synthesis DNA Polymerase Kappa Is Indispensable for DNA Repair Synthesis in Cisplatin Exposed Dorsal Root Ganglion Neurons.Mitochondrial membrane fluidity is consistently increased in different models of Huntington disease: restorative effects of olesoxime.Cisplatin Toxicity in Dorsal Root Ganglion Neurons Is Relieved by Meclizine via Diminution of Mitochondrial Compromise and Improved Clearance of DNA Damage.Chemotherapy-induced peripheral neuropathy: A current review.α9-containing nicotinic acetylcholine receptors and the modulation of pain.The calpain-suppressing effects of olesoxime in Huntington's disease.miR-15b mediates oxaliplatin-induced chronic neuropathic pain through BACE1 down-regulation.A Mechanistic Understanding of Axon Degeneration in Chemotherapy-Induced Peripheral Neuropathy.Altered discharges of spinal neurons parallel the behavioral phenotype shown by rats with bortezomib related chemotherapy induced peripheral neuropathyCisplatin induced sensory neuropathy is prevented by vascular endothelial growth factor-A.The antioxidant effects of the flavonoids rutin and quercetin inhibit oxaliplatin-induced chronic painful peripheral neuropathy.
P2860
Q28484947-B6814EBE-872F-472D-958D-B9F6B545A396Q28534579-68993A77-8EA6-47AA-844B-92E48984E15FQ28834071-8E713411-A229-4895-B4FF-26C9A3BA2013Q33571709-2F42748D-78E1-4341-AC4D-F02ED9A1BC07Q33868520-40FBB01C-C56B-44E0-8997-E9B998677274Q33947251-64DC35CF-2142-4D10-9661-63574CBD5CB0Q34056025-38DE1D2E-6E36-4D08-96CB-EB863974E4CDQ34765028-9AF96629-2022-4C03-A1A8-6D2335A71862Q35170603-4A131655-A3F5-4B5C-BEB7-7F2088B03A81Q36006338-FCA81262-002F-4AAA-BF4C-1EF967CDC617Q36174729-2BE9EFDE-71E9-4BFD-B287-31FFA06503FDQ36261283-DD6B60E8-EAC9-457F-BDE0-056DE46FD179Q36421901-522EDF91-DA5A-411A-A5CA-38765E9B8393Q36648880-A64F133B-E938-4ABD-A21C-DCF9084FB147Q36750823-BC6B2AF2-296F-4298-BB91-CBEAA195AD4CQ36909043-D4691E4C-67EA-45E2-B1F4-4AFF6592BE3AQ36927755-3A8B149A-133F-438D-B2FD-4BF698BD83FCQ36963585-A70A93EB-CD53-4A71-A559-E1F2FAF67F7EQ36977059-AB8DE22D-E1F4-478D-9200-B53943C2EB62Q36988206-BD4019F4-9302-4243-A8DC-92932EAA0D96Q37107220-17F1F383-61AC-45BD-9F7A-94D0103A1597Q37170634-26266D1B-18A6-43EB-A78D-EC96D6A8EB79Q37362035-55200E61-0742-40D0-B28A-8DBDDA63FA02Q37399781-55B65028-0147-438D-BDE1-DB4E1AC6CF46Q37583394-BBA1E202-8017-4F1C-9421-D0DC804A3E16Q37726633-3302202C-E449-4481-9D5E-2431BDEF5A67Q38154874-5B3370E9-0906-4D1E-8E11-417D472BD606Q38330759-4143B8B0-72CD-4F0E-9667-61978FFC5F97Q38522262-B2F15D38-3022-4D76-8083-B94C4625B031Q38845960-5FEA3A88-CBCC-4BC2-8851-ACC067D05844Q39014966-A0F9FE89-2080-4941-B5B4-59E2B83B5591Q39178503-FA9FA0D3-0469-40A2-9195-C69A10A33D40Q39293928-6FA675EF-2445-41F6-BD8F-90746927DC9FQ39405111-A76A5522-FC1B-4AC0-8E63-2D5E2438B1EEQ40402039-17C043BE-AD32-470D-940C-3C14AB3156A0Q40409159-3A0774EC-B853-4AE1-9594-2BA6810D31E4Q41606031-F44E7C01-3D6D-48F9-B463-B62C6A3E0573Q41943563-265B25E6-6CC4-4E34-8E1B-D4CD3367E82CQ41949087-2EB1BECE-6C06-40EC-A3D4-46CC433AE542Q42119079-F5AD0B45-6489-44BE-A395-0A1CDAA64508
P2860
Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Characterization of oxaliplati ...... ropathy induced by paclitaxel.
@ast
Characterization of oxaliplati ...... ropathy induced by paclitaxel.
@en
type
label
Characterization of oxaliplati ...... ropathy induced by paclitaxel.
@ast
Characterization of oxaliplati ...... ropathy induced by paclitaxel.
@en
prefLabel
Characterization of oxaliplati ...... ropathy induced by paclitaxel.
@ast
Characterization of oxaliplati ...... ropathy induced by paclitaxel.
@en
P2093
P2860
P1433
P1476
Characterization of oxaliplati ...... ropathy induced by paclitaxel.
@en
P2093
P2860
P304
P356
10.1016/J.NEUROSCIENCE.2011.12.023
P407
P577
2011-12-20T00:00:00Z